Source: Annual Congress 2011 - COPD: human studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ostrovskyy, O. Varunkiv, M. Kulynych-Miskiv, I. Savelikhina (Ivano-Frankivsk, Ukraine). The effects of morphological remodeling of the bronchi on the neocollagenesis processes in patients with COPD stage 2 during exacerbation. Eur Respir J 2011; 38: Suppl. 55, 729

Member's Comments

No comment yet.

Related content which might interest you: The peculiarities of the cascade of the bronchial asthma patients‘ cytokines depending on the stage of disease Source: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006 The relationship between bronchial inflammation and markers of disease progression in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 Protective effects of tiotropium bromide on the morphological remodeling of the bronchi on the neocollagenesis processes in patients with moderate COPD during exacerbation Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Infectional factors influences on expressiveness of inflammatory process and structural changes in bronchial mucosa at COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 COPD exacerbation influence on chromatin organization in bronchial epithelium cells Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Smoking induced pulmonary vascular remodelling in patients with mild COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Tezepelumab decreases matrix remodelling and inflammatory pathways in patients with asthma Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma Year: 2019 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 The role of small-airway inflammation and remodeling in asthma Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance Year: 2013 Effect of roflumilast on morphological changes in mucous membrane of bronchi in patients with severe chronic obstructive pulmonary disease Source: International Congress 2014 – Predictors Year: 2014 Fibrocyte accumulation in the airway walls of COPD patients Source: Eur Respir J, 54 (3) 1802173; 10.1183/13993003.02173-2018 Year: 2019 Conclusion: clinical phenotypes of asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Differential response of COPD bronchial epithelium to LPS in a three-dimensional culture model Source: Annual Congress 2006 - Airway epithelial cells in inflammation Year: 2006 Gender effect on airway and lung parenchyma remodelling in an experimental model of chronic allergic asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008 Evaluating the effects of pulmonary rehabilitation in patients with COPD in early and late disease stages. Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Update on the roles of distal airways in COPD Source: Eur Respir Rev 2011; 20: 7-22 Year: 2011 The impact of vaccination on the dynamics of bronchial and systemic inflammation in patients with COPD and CHD Source: International Congress 2017 – COPD management Year: 2017 Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021